Update on Coronary Involvement in Fabry Disease
Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender.
Main Author: | |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)
2016
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S2326-45942016000100801 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S2326-459420160001008012019-05-28Update on Coronary Involvement in Fabry DiseaseCabrera,Gustavo Fabry disease coronary involvement microvascular involvement coronary syndromes acute myocardial infarction coronary revascularization Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender.info:eu-repo/semantics/openAccessLatin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)Journal of Inborn Errors of Metabolism and Screening v.4 20162016-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801en10.1177/2326409816679427 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Cabrera,Gustavo |
spellingShingle |
Cabrera,Gustavo Update on Coronary Involvement in Fabry Disease |
author_facet |
Cabrera,Gustavo |
author_sort |
Cabrera,Gustavo |
title |
Update on Coronary Involvement in Fabry Disease |
title_short |
Update on Coronary Involvement in Fabry Disease |
title_full |
Update on Coronary Involvement in Fabry Disease |
title_fullStr |
Update on Coronary Involvement in Fabry Disease |
title_full_unstemmed |
Update on Coronary Involvement in Fabry Disease |
title_sort |
update on coronary involvement in fabry disease |
description |
Abstract Fabry disease is a multisystemic disorder with consequent morbidity and mortality at an early age in patients of both genders. Although renal failure has been previously described as the cause of death with the highest prevalence, recent studies, based on the analysis of the population recorded in the Fabry Registry, reported that 40% of deaths had a cardiovascular origin. Data from the same registry emphasize the high risk for these patients suffering cardiovascular events—particularly acute myocardial infarction—and to the fact that this risk is higher for those patients who need dialysis. Microvascular dysfunction is a constant in patients with Fabry disease, which affects young patients, independently from other cardiac involvement manifestations—such as left ventricular hypertrophy—and from the patient’s gender. |
publisher |
Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT) |
publishDate |
2016 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942016000100801 |
work_keys_str_mv |
AT cabreragustavo updateoncoronaryinvolvementinfabrydisease |
_version_ |
1756441180489383936 |